Goldman Sachs
MOR

Goldman Sachs’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Goldman Sachs’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,500
Closed -$191K – 6175
2024
Q2 		$191K Buy
+10,500
New +$191K ﹤0.01% 5281

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs's MOR Position: Q2 2024 in Review

Goldman Sachs sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 636,016 shares — an estimated $11.6M sold.

Goldman Sachs first reported a position in MOR in Q3 2019 and held it in 17 quarters. The position peaked at $11.5M in Q1 2024. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Goldman Sachs reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 636,016 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $11.6M.
  • Goldman Sachs first reported a position in MorphoSys AG American Depositary Shares in Q3 2019 and held it in 17 quarters.
  • Goldman Sachs's MorphoSys AG American Depositary Shares position peaked at $11.5M in Q1 2024.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.